Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer

M. Shimada, J. Kigawa, N. Terakawa, A. Yoshizaki, T. Shoji, M. Suzuki, M. Hatae, H. Tsuda, M. Ohwada, T. Sugiyama

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Fingerprint Dive into the research topics of 'Phase I trial of paclitaxel, doxorubicin, and carboplatin (TAC) for the treatment of endometrial cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences